Washington, DC—The U.S. House of Representatives advanced two bipartisan measures authored by Congressman Brian Fitzpatrick (PA-08) to prevent prescription drug abuse.
WASHINGTON – Congressman Brian Fitzpatrick release a statement after the House of Representatives overwhelmingly voted to repeal the Medical Device Tax.
Washington, DC – Bipartisan legislation introduced by Congressman Brian Fitzpatrick (PA-08) to combat the opioid epidemic unanimously passed the House Tuesday afternoon. The REACH OUT Act will ensure that prescribers have the necessary tools for preventing prescription drug abuse.
WASHINGTON, DC – Congressmen Brian Fitzpatrick (R-PA), Carlos Curbelo (R-FL), and Mike Thompson (D-CA) authored a bipartisan bill to help medical professionals implement best practices for prescribing opioids. Their REACH OUT Act unanimously passed the Energy and Commerce Committee and will be considered by the full House this month.
WASHINGTON, D.C. – Right to Try Legislation passed the House Tuesday evening with a bipartisan vote of 250-169. The bill – The Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act [S.204], a Senate companion bill to Congressman Brian Fitzpatrick’s Right to Try legislation, follows months of legislative efforts and improves access to experimental treatments for patients with terminal illnesses. The bill now awaits the President’s signature.
WASHINGTON, DC – Today, Congressmen Brendan F. Boyle (D-PA) and Brian K. Fitzpatrick (R-PA) led a bipartisan letter demanding the release of a study on the human health effects of perfluorooctanesulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) that was reportedly suppressed by EPA staff out of concern for negative public relations. The letter also demands an explanation for the study’s suppression.
WASHINGTON, D.C. - Congressman Brian Fitzpatrick (PA-08), co-chair of the ALS Caucus, announced Thursday that his companion bill, the Right to Try Act of 2017 [S.204], which unanimously passed the Senate last year, will be voted on next week in the House. The announcement resulted from Fitzpatrick’s early morning meeting with House Leadership.